| NCT ID | NCT06943105 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hong Kong Metropolitan University |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 172 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 172 participants in total. It began in 2025-05-01 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomised controlled trial (RCT) aims to evaluate the effectiveness of face-to-face Nonviolent Communication (NVC) intervention in improving parents' mental well-being and NVC skills, reducing parenting stress, depression and anxiety symptoms, and child emotional and behavioural problems. A total of 172 parents with primary-school-age children will be recruited and randomly assigned to an intervention group or a waitlist control group. The intervention group will receive six weekly 1.5-hour face-to-face NVC training sessions delivered by trained social workers. Five to ten social workers will be trained by professional NVC trainers through a train-the-trainer workshop, including three sessions. Each social worker will be assessed before (TTT1), after (TTT2) the workshops and 10 months (TTT3). Assessments for participants will be conducted at baseline (T1), immediately post-intervention (T2), and at three-month follow-up (T3). After completing the assessments, the waitlist control group will receive the same sessions. Qualitative interviews will be conducted to explore participants' experiences and perceptions of NVC.
Eligibility Criteria
Inclusion Criteria: * 1\) parents aged 24-59 years with children of primary school age; * 2\) with mild to severe depressive symptoms (score \>5 on the Patient Health Questionnaire (PHQ)-9) (Kroenke et al., 2001) and/or mild to severe anxiety symptoms (score \>5 on the General Anxiety Disorder (GAD)-7) (Spitzer et al., 2006); and * 3\) Hong Kong residents who can understand Cantonese. Exclusion Criteria: * 1\) under psychiatric treatment, psychotherapy groups and are classified as unstable cases based on the judgment of the recruiting social workers; * 2\) participating in other related parenting programmes.
Contact & Investigator
Grace Yuying Sun
PRINCIPAL INVESTIGATOR
Hong Kong Metropolitan University
Frequently Asked Questions
Who can join the NCT06943105 clinical trial?
This trial is open to participants of all sexes, aged 24 Years or older, up to 59 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06943105 currently recruiting?
Yes, NCT06943105 is actively recruiting participants. Contact the research team at gsun@hkmu.edu.hk for enrollment information.
Where is the NCT06943105 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06943105 clinical trial?
NCT06943105 is sponsored by Hong Kong Metropolitan University. The principal investigator is Grace Yuying Sun at Hong Kong Metropolitan University. The trial plans to enroll 172 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.